###begin article-title 0
###xml 81 86 <span type="species:ncbi:10090">Mouse</span>
Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease
###end article-title 0
###begin p 1
Conceived and designed the experiments: GB. Performed the experiments: CLB RB LM HM MM. Analyzed the data: CLB RB LM JN MM. Contributed reagents/materials/analysis tools: BW. Wrote the paper: CLB GB.
###end p 1
###begin p 2
###xml 940 945 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC7</italic>
###xml 1067 1072 1067 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1226 1231 1226 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1482 1487 1482 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 693 698 <span type="species:ncbi:10090">mouse</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
Huntington's disease (HD) is an inherited, progressive neurological disorder caused by a CAG/polyglutamine repeat expansion, for which there is no effective disease modifying therapy. In recent years, transcriptional dysregulation has emerged as a pathogenic process that appears early in disease progression. Administration of histone deacetylase (HDAC) inhibitors such as suberoylanilide hydroxamic acid (SAHA) have consistently shown therapeutic potential in models of HD, at least partly through increasing the association of acetylated histones with down-regulated genes and by correcting mRNA abnormalities. The HDAC enzyme through which SAHA mediates its beneficial effects in the R6/2 mouse model of HD is not known. Therefore, we have embarked on a series of genetic studies to uncover the HDAC target that is relevant to therapeutic development for HD. HDAC7 is of interest in this context because SAHA has been shown to decrease HDAC7 expression in cell culture systems in addition to inhibiting enzyme activity. After confirming that expression levels of Hdac7 are decreased in the brains of wild type and R6/2 mice after SAHA administration, we performed a genetic cross to determine whether genetic reduction of Hdac7 would alleviate phenotypes in the R6/2 mice. We found no improvement in a number of physiological or behavioral phenotypes. Similarly, the dysregulated expression levels of a number of genes of interest were not improved suggesting that reduction in Hdac7 does not alleviate the R6/2 HD-related transcriptional dysregulation. Therefore, we conclude that the beneficial effects of HDAC inhibitors are not predominantly mediated through the inhibition of HDAC7.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 322 325 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Bates1">[1]</xref>
###xml 390 392 390 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HD</italic>
###xml 485 488 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Huntingtons1">[2]</xref>
###xml 673 676 673 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-DiFiglia1">[3]</xref>
###xml 678 681 678 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Gutekunst1">[4]</xref>
###xml 773 776 773 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Mangiarini1">[5]</xref>
###xml 778 781 778 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Davies1">[6]</xref>
###xml 997 1000 997 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Carter1">[7]</xref>
###xml 1002 1005 1002 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Lione1">[8]</xref>
###xml 1193 1196 1193 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Stack1">[9]</xref>
###xml 692 697 <span type="species:ncbi:10090">mouse</span>
###xml 728 733 <span type="species:ncbi:9606">human</span>
###xml 910 915 <span type="species:ncbi:9606">human</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1221 1226 <span type="species:ncbi:10090">mouse</span>
Huntington's disease (HD) is an autosomal dominant late-onset progressive neurodegenerative disorder with a mean age of onset of 40 years. Symptoms include psychiatric disturbances, motor disorders, cognitive decline and weight loss, disease duration is 15-20 years and there are no effective disease modifying treatments [1]. The HD mutation is an expanded CAG trinucleotide repeat in the HD gene that is translated into a polyglutamine (polyQ) repeat in the huntingtin (Htt) protein [2]. Neuropathologically, the disease is characterized by neuronal cell loss in the striatum, cortex and other brain regions and the deposition of nuclear and cytoplasmic polyQ aggregates [3], [4]. The R6/2 mouse model expresses exon 1 of the human HD gene with more than 150 CAG repeats [5], [6]. The R6/2 phenotype has an early onset and rapid and reproducible phenotype progression that recapitulates many features of the human disease. Motor and cognitive abnormalities can be detected before 6 weeks of age [7], [8], and mice are rarely kept beyond 15 weeks. PolyQ aggregates are clearly apparent in some brain regions from 3 to 4 weeks of age and striatal cell loss has been documented at later stages [9]. This suggests that the mouse phenotype is predominantly caused by neuronal dysfunction.
###end p 4
###begin p 5
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Cha1">[10]</xref>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Strand1">[11]</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Kuhn1">[13]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Kuo1">[14]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Gallinari1">[16]</xref>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Steffan1">[17]</xref>
###xml 976 980 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Bates2">[19]</xref>
###xml 1161 1165 1161 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-McCampbell1">[20]</xref>
###xml 1166 1170 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Thomas1">[28]</xref>
###xml 1306 1310 1306 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-SadriVakili2">[29]</xref>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 268 273 <span type="species:ncbi:10090">mouse</span>
Transcriptional dysregulation occurs early in the molecular pathology of HD and has been recapitulated across multiple HD model systems (reviewed in [10]). RNA Affymetrix expression profiles of brain regions and muscle from both the R6/2 transgenic mouse and knock-in mouse models of HD show high correlation to expression profiles from HD post-mortem tissue [11]-[13]. The molecular mechanisms that underlie these selective transcriptional disturbances are unknown and remain the subject of investigation. The control of eukaryotic gene expression in part depends on the modification of histone proteins associated with specific genes with the acetylation and deacetylation of histones playing a critical role in gene expression [14]-[16]. Studies in numerous HD models have shown that mutant huntingtin expression leads to a change in histone acetyltransferase (HAT) activity and suggest that aberrant HAT activity may contribute to transcriptional dysregulation in HD [17]-[19]. Supporting this view, administration of histone deacetylase (HDAC) inhibitors such as suberoylanilide hydroxamic acid (SAHA) consistently shows therapeutic potential in HD models [20]-[28], at least partly through increasing the association of acetylated histones with down-regulated genes and correcting mRNA abnormalities [29].
###end p 5
###begin p 6
###xml 98 122 98 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Yang1">[30]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Xu1">[31]</xref>
###xml 663 686 663 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 691 713 691 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Bates2">[19]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Pallos1">[32]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Gregoretti1">[33]</xref>
###xml 98 122 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 663 686 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 691 713 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 880 883 <span type="species:ncbi:9606">man</span>
There are three major classes of mammalian HDACs, based on their structural homology to the three Saccharomyces cerevisiae HDACs: rpd3 (class I), hda1 (class II) and sir2 (class III). Class I comprises HDAC1, -2, -3 and -8, class IIa HDAC4, -5, -7 and -9, class IIb HDAC6 and -10 and HDAC11 (class IV) shows homology to both rpd3 and hda1 [30]. Pan-HDAC inhibitors such as SAHA target the zinc-dependent HDACs 1-11 and not the NAD+ dependent class III HDACs (the seven sirtuins, SIRT1-7) [31]. In order to gain insight into which HDACs must be inhibited in order to alleviate HD-related phenotypes, genetic approaches have been used to complement pharmacology in Drosophila melanogaster and Caenorhabditis elegans HD models [19], [32]. However, as HDACs show differential levels of evolutionary conservation [33], the extent to which these studies will inform drug development in man has yet to be demonstrated.
###end p 6
###begin p 7
###xml 584 598 584 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC7 in vitro</italic>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Dokmanovic1">[34]</xref>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 831 833 831 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HD</italic>
###xml 844 849 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 947 952 947 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Chang1">[35]</xref>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1028 1033 1028 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1143 1148 1143 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1188 1193 1188 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1234 1239 1234 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1356 1361 1356 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1416 1421 1416 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
###xml 799 804 <span type="species:ncbi:10090">mouse</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
###xml 940 946 <span type="species:ncbi:10090">murine</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1056 1060 <span type="species:ncbi:10090">mice</span>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
###xml 1347 1351 <span type="species:ncbi:10090">mice</span>
The molecular mechanisms by which SAHA exerts its beneficial and toxic effects are currently not clear, nor whether the beneficial and toxic effects can be dissociated. We therefore need to systematically interrogate known targets of SAHA genetically in order to identify the HDAC(s) that present therapeutic targets relevant to HD. As a consequence, we have embarked on a serried of genetic crosses between the R6/2 mouse and specific HDAC knock-out mouse lines. It has previously been shown that in addition to enzyme inhibition, SAHA treatment selectively suppresses expression of HDAC7 in vitro[34], thus representing a potential molecular avenue by which pan-HDAC inhibition exerts a beneficial effect. We confirmed that chronic administration of SAHA decreases Hdac7 mRNA expression levels in mouse brain irrespective of the HD genotype. Hdac7 knockout mice were previously generated through a targeted inactivation of the endogenous murine Hdac7 gene [35]. Hdac7 null mice are embryonic lethal and die at E11.0. However, Hdac7 heterozygote knockout mice were found to be viable and fertile, with no overt phenotype. We demonstrate that Hdac7 mRNA and protein levels are reduced in Hdac7+/- heterozygous knock-out mice and that Hdac7 expression is not altered by the presence of the R6/2 transgene. We performed a genetic cross between R6/2 mice and Hdac7+/- heterozygotes and found that genetic knock-down of Hdac7 fails to confer any improvement to a number of physiological, behavioral and transcriptional phenotypes. We conclude that neither inhibition of HDAC7 nor its downregulation contributed significantly to the beneficial effects that we observed upon administration of SAHA.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
The expression of Hdac7 is decreased in R6/2 brain in response to chronic treatment with SAHA
###end title 9
###begin p 10
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Richon1">[36]</xref>
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Codd1">[37]</xref>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC7</italic>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Dokmanovic1">[34]</xref>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 684 688 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly1">[23]</xref>
###xml 982 987 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1044 1053 1041 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g001">Figure 1A</xref>
###xml 1114 1127 1111 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7 in vivo</italic>
###xml 402 408 <span type="species:ncbi:10090">murine</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 1038 1042 <span type="species:ncbi:10090">mice</span>
SAHA has been described as a pan-HDAC enzyme inhibitor [36], [37]. In addition, it was recently shown that treatment of a number of cell lines with SAHA resulted in the specific down-regulation of HDAC7 at the mRNA level [34]. To determine whether the expression of Hdac7 might be similarly altered by the administration of SAHA in vivo, we established a quantitative real time PCR assay (RT-qPCR) for murine Hdac7. We had previously conducted an efficacy trial to assess the effects of the administration of SAHA, when complexed with hydroxypropyl-beta-cyclodextrin at a concentration of 0.67 g/L in the drinking water, and observed a considerable improvement in RotaRod performance [23]. The WT and R6/2 mice that had been treated with SAHA or vehicle in this experiment had been sacrificed at 13 weeks of age and we still had access to cerebellar cDNA that had been prepared from the brains of these mice. We were able to show that SAHA significantly decreased the expression of Hdac7 in the cerebellum of both wild type (WT) and R6/2 mice (Figure 1A). Therefore, SAHA has a similar effect on the expression of Hdac7 in vivo as has been described in cell culture and this could contribute to the beneficial effects of SAHA administration.
###end p 10
###begin title 11
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
SAHA specifically down regulates Hdac7 mRNA levels.
###end title 11
###begin p 12
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actb</italic>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grin1</italic>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 620 628 620 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7+/&#8722;</italic>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 888 893 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 906 911 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1094 1099 1090 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1405 1406 1397 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 253 258 <span type="species:ncbi:10090">mouse</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
Hdac7 expression is decreased in Hdac7+/- mice and not altered by the presence of the R6/2 transgene. (A) Hdac7 mRNA expression levels are shown as relative expression ratios to the geometric mean of the Actb and Grin1 housekeeping genes in 13 week old mouse cerebellum from SAHA-treated WT (grey) and R6/2 (black) mice together with vehicle treated WT (white) and R6/2 (striped) mice (n>8 per genotype). Error bars are S.E.M. (B, C) Hdac7 expression level is shown as a relative expression ratio to the geometric mean of three housekeeping genes in (B) striatum and (C) cerebellum of 14 week old wild-type (Wt, white), Hdac7+/- knockdown (Hdac7) (grey), R6/2 (black) and R6/2 mice with Hdac7+/- knockdown (R6/2-Hdac7, striped) mice (n>8 per genotype). Error bars are S.E.M. (D) Representative western immunoblot of 50 microg of cortical homogenate from 14 week old wild-type (WT), R6/2, Hdac7+/- and R6/2-Hdac7+/- mice. Blots were probed with an antibody that recognizes Hdac7 (120 kDa) and a non-specific band (70 kDa). (E) Quantification of Hdac7 protein expression levels in WT (white) and Hdac7+/- (grey) mice. Quantification was performed on blots containing four samples per genotype using the non-specific band for reference. Blots were additionally probed with an antibody to alpha-tubulin to confirm equal protein loading (data not shown). Error bars represent standard deviation from the mean (n = 4). * p<0.05, ** p<0.01, *** p<0.001.
###end p 12
###begin title 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
Hdac7 expression level is unaffected by the expression of the R6/2 transgene
###end title 13
###begin p 14
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac1</italic>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Schuettengruber1">[38]</xref>
###xml 501 506 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 714 719 714 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 756 761 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 923 938 923 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g001">Figure 1B and C</xref>
###xml 978 983 978 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1211 1226 1211 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g001">Figure 1D and E</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
We found heterozygous Hdac7 knockout mice to be viable and fertile, with no overt phenotype. Therefore, prior to interpreting the results of a genetic cross to determine whether heterozygous knock-down of Hdac7 has a beneficial effect on R6/2 HD-related phenotypes, it was important to show that (1) Hdac7 expression is reduced in Hdac7+/- knock-out mice: that Hdac7 is not auto-regulated to wild type levels as is the case for Hdac1[38] and (2) that the presence of the R6/2 transgene does not alter Hdac7 expression levels. RT-qPCR was performed on cDNA prepared from the striatum and cerebellum of 15 week old wild type (WT), Hdac7 heterozygote (Hdac7+/-), R6/2 transgenic (R6/2) and R6/2 mice heterozygote for Hdac7 (R6/2-Hdac7+/-) mice. We found that Hdac7 expression levels were significantly decreased in the striatum and cerebellum of Hdac7+/- heterozygote mice, irrespective of the presence of the R6/2 transgene (Figure 1B and C). Furthermore, we saw no difference in Hdac7 expression levels between WT and R6/2 mice in either brain region. Western blotting was performed on whole cell lysates from 15 week cortices. We found HDAC7 protein levels to be in agreement with the RNA expression profiling (Figure 1D and E).
###end p 14
###begin title 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Hdac7 is expressed in neuronal populations in the mouse brain
###end title 15
###begin p 16
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Martin1">[39]</xref>
###xml 796 804 796 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g002">Figure 2</xref>
###xml 607 612 <span type="species:ncbi:10090">mouse</span>
An important feature of the class IIa HDACs is their ability to shuttle between the nucleus and the cytoplasm. Precise regulation of the subcellular distribution of class IIa HDACs is intimately linked to the control of their activity and plays a pivotal role in cellular processes and organ development [39]. Previous observations have highlighted a differential subcellular localization of HDAC7 in different cell lines and body tissues, suggesting that the control of subcellular localization and function of HDAC7 differs with respect to the cell type. To explore the expression pattern of Hdac7 in the mouse brain we performed immunohistochemistry to coronal sections of WT and R6/2 brains from animals at 14 weeks of age. HDAC7 is present in both the nucleus and cytoplasm in the striatum (Figure 2), cortex and cerebellum (data not shown) of both WT and R6/2 brains. It is present in all neurons, but interestingly appears to be absent from the nuclei of at least some non-neuronal cell populations.
###end p 16
###begin title 17
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
HDAC7 is present in the nucleus and cytoplasm of neuronal cells in the mouse striatum.
###end title 17
###begin p 18
###xml 101 116 <span type="species:ncbi:10090">transgenic mice</span>
Representative confocal microscopy images of coronal sections of brains from wild-type (WT) and R6/2 transgenic mice at 14 weeks of age immuoprobed with antibodies to NeuN to identify neurons and with anti-HDAC7. Nuclei were visualized using TO-PRO-3 (blue). Scale bar 20 microm.
###end p 18
###begin title 19
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
Genetic reduction of Hdac7 does not modify the R6/2 phenotype
###end title 19
###begin p 20
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly2">[40]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Woodman1">[42]</xref>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005747-t001">Table 1</xref>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
We have previously established a set of quantitative tests with which to monitor progressive behavioral phenotypes in R6/2 mice [40]-[42]. To generate mice for this analysis, male R6/2 mice were bred with female Hdac7 heterozygote knock-out mice (Hdac7+/-) to produce at least 10 female mice from each genotype (WT, n = 10; Hdac7+/-, n = 13; R6/2, n = 14; R6/2-Hdac7+/-, n = 12), which were born over a period of 5 days. The CAG repeat size was well matched between the R6/2 and R6/2-Hdac7+/- groups (P = 0.102) (Table 1). Weight gain, RotaRod performance, grip strength and exploratory activity were monitored from 4 to 15 weeks of age, and in each case, a specific test was performed on the same day and at the same time during the weeks in which measurements were taken.
###end p 20
###begin title 21
###xml 11 15 <span type="species:ncbi:10090">mice</span>
Details of mice used in the study.
###end title 21
###begin p 22
###xml 52 61 52 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g003">Figure 3A</xref>
###xml 123 129 123 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 186 193 186 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(4,495)</sub>
###xml 214 223 214 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g003">Figure 3A</xref>
###xml 274 280 274 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 321 328 321 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(4,495)</sub>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 436 442 436 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 516 523 516 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(4,495)</sub>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
Mice were weighed weekly from 4 to 15 weeks of age (Figure 3A). As expected, R6/2 mice weighed less overall than WT mice [F(1,45) = 5.18, P = 0.028] and gained weight at a slower rate [F(4,495) = 18.546, P<0.001] (Figure 3A). There was no difference in the overall weight [F(1,45) = 0.024, P = 0.877] or in weight gain [F(4,495) = 1.19, P = 0.316] between WT and Hdac7+/- mice. Genetic reduction of Hdac7 had no effect on R6/2 weight [F(1,45) = 1.064, P = 0.308] and did not attenuate the rate of R6/2 weight loss [F(4,495) = 1.168, P = 0.327]. Therefore, genetic reduction of Hdac7 does not improve the weight loss phenotype in the R6/2 mice.
###end p 22
###begin title 23
HDAC7 genetic reduction does not alter R6/2 physiological or behavioural phenotypes.
###end title 23
###begin p 24
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
The R6/2 phenotypes (A) weight loss, (B) hypothermia, (C) impaired RotaRod performance and (D) reduced grip strength are not ameliorated by genetic knock-down of Hdac7 expression. Error bars represent S.E.M. Shown to the right of each graph are the P values arising from GLM repeated measures ANOVA analysis of the data.
###end p 24
###begin p 25
###xml 89 98 89 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g003">Figure 3B</xref>
###xml 142 148 142 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 235 241 235 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 334 340 334 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 378 384 378 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 477 483 477 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 551 557 551 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1.45)</sub>
###xml 611 615 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
The body temperature of the mice was recorded at 14 and 15 weeks of age by rectal probe (Figure 3B). R6/2 mice were found to be hypothermic [F(1,45) = 69.781, P<0.001], which worsened over the course of the week between measurements [F(1,45) = 4.315, P = 0.044]. There was no overall change in body temperature in the Hdac7+/- mice [F(1,45) = 0.416, P = 0.552], nor with time [F(1,45) = 2.05, P = 0.159]. There was no effect of the Hdac7+/- genotype on R6/2 body temperature [F(1,45) = 1.276, P = 0.265], nor the progression of the R6/2 hypothermia [F(1.45) = 0.002, P = 0.968]. Therefore, genetic reduction of Hdac7 does not improve the hypothermia that occurs in symptomatic R6/2 mice.
###end p 25
###begin p 26
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly2">[40]</xref>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 293 302 293 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g003">Figure 3C</xref>
###xml 412 419 412 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1 ,45)</sub>
###xml 467 475 467 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(2 ,900)</sub>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 562 568 562 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 614 621 614 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(2,900)</sub>
###xml 796 800 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 859 866 859 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1 ,45)</sub>
###xml 916 925 916 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g003">Figure 3C</xref>
###xml 1042 1049 1042 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(2,900)</sub>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
RotaRod performance is a sensitive indicator of balance and motor coordination, which has been reliably shown to decline in R6/2 mice [40]. Using this test, we found that R6/2 and R6/2-Hdac7+/- mice performed similarly with age and that the performance of Hdac7+/- and WT mice was equivalent (Figure 3C). Consistent with previous results, the overall RotaRod performance of R6/2 was impaired as compared to WT [F(1 ,45) = 40.634, P<0.001] and deteriorated with age [F(2 ,900) = 9.119, P<0.001]. Overall, the performance of Hdac7+/- mice did not differ from WT [F(1,45) = 0.047, P = 0.83] but did change with age [F(2,900) = 4.427, P = 0.009] however, this is most likely the result of the exceptionally good, but atypical, performance of the WT mice at four weeks. There was no overall effect of Hdac7 knock-down on the RotaRod performance of the R6/2 mice [F(1 ,45) = 0.194, P = 0.661] and examination of the data (Figure 3C) indicates that the statistically significant interaction between the genotypes over the course of the experiment [F(2,900) = 4.516, P = 0.009] is, once again, due to the performance of the WT mice at 4 weeks of age and not a reflection of an alteration in the R6/2 phenotype.
###end p 26
###begin p 27
###xml 72 81 72 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g003">Figure 3D</xref>
###xml 165 171 165 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 231 238 231 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(3,360)</sub>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 336 343 336 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1, 45)</sub>
###xml 404 411 404 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(3,360)</sub>
###xml 454 458 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 505 511 505 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1,45)</sub>
###xml 545 552 545 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(3,360)</sub>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
Forelimb grip strength was assessed at 4, 7, 9, 11 and 13 weeks of age (Figure 3D). Consistent with previous data, R6/2 mice performed significantly worse than WT [F(1,45) = 16.588, P<0.001] and performance deteriorated with age [F(3,360) = 13.248, P<0.001]. The grip strength of Hdac7+/- mice was comparable to WT mice, both overall [F(1, 45) = 0.474, P = 0.495] and over the course of the experiment [F(3,360) = 1.055, P = 0.369]. Genetic reduction of Hdac7 did not improve R6/2 grip strength overall [F(1,45) = 0.45, P = 0.833] or with age [F(3,360) = 2.131, P = 0.102].
###end p 27
###begin p 28
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly3">[41]</xref>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005747-t002">Table 2</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly3">[41]</xref>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005747-t002">Table 2</xref>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 915 919 915 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 1015 1019 1015 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 169 173 <span type="species:ncbi:10090">Mice</span>
###xml 344 348 <span type="species:ncbi:10090">Mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
Exploratory activity was assessed fortnightly from 5 to 13 weeks of age as described previously [41] and analyzed by repeated measures general linear model (GLM) ANOVA. Mice were assessed for a period of 60 min for total activity, mobility and rearing and the P-values obtained through the analyses are displayed in Table 2 for each parameter. Mice of all genotypes exhibit most activity during the first 15 minutes of the assessment period [41]. R6/2 mice show an overall hypoactivity relative to WT mice from 11 weeks (Table 2, R6/2) although the pattern of activity over the course of the 60 min period was significantly different between R6/2 and WT mice (R6/2*time) by five weeks of age. Hdac7+/- mice were indistinguishable from WT mice, both in overall activity (HDAC7) and in the 60 minute pattern of activity (HDAC7*time). There was no overall improvement in R6/2 hypoactivity through genetic reduction of Hdac7 (R6/2*HDAC7), nor was the R6/2 pattern of hypoactivity changed (R6/2*HDAC7*time). In summary, Hdac7 genetic reduction does not improve hypoactivity in the R6/2 mice.
###end p 28
###begin title 29
Statistical analysis of exploratory activity.
###end title 29
###begin p 30
###xml 25 32 25 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005747-t002">table 2</xref>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">Mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
The numbers displayed in table 2 indicate the P-values for each of the parameters analysed (genotype of mice, age of mice and time in the activity cages), with significant P-values highlighted for ease of interpretation. Mice in activity cages are shown to behave differently with respect to measures of exploratory behaviour (as determined by measuring activity, mobility and rearing) over a period of one hour (Time). Wild-type and R6/2 mice exhibit reproducible differences in measures of exploratory behaviour with R6/2 mice developing a progressive hypoactivity that becomes significant at older ages as demonstrated by decreased activity and mobility in addition to decreased rearing behaviour (R6/2 genotype and R6/2 genotype*time). Hdac7 reduction does not influence the behaviour of mice for any parameter assessed (Hdac 7 genotype and Hdac7*time) and furthermore, there appears no interaction between Hdac7 and R6/2 genotypes (R6/2*Hdac7 and R6/2*Hdac7*time).
###end p 30
###begin title 31
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
Hdac7 genetic reduction does not ameliorate the dysregulated expression of genes of interest in R6/2 mouse brains
###end title 31
###begin p 32
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Thomas1">[28]</xref>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-SadriVakili2">[29]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Ryu1">[43]</xref>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdh</italic>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Kuhn1">[13]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Woodman1">[42]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Benn1">[44]</xref>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 676 685 676 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g004">Figure 4A</xref>
###xml 706 715 706 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g004">Figure 4B</xref>
###xml 765 771 765 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igfbp5</italic>
###xml 874 883 874 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g004">Figure 4B</xref>
###xml 982 991 982 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g004">Figure 4C</xref>
###xml 1025 1034 1025 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005747-g004">Figure 4D</xref>
###xml 1053 1058 1053 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 396 403 <span type="species:ncbi:9606">patient</span>
###xml 521 526 <span type="species:ncbi:10090">mouse</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
As HDAC inhibitors have been shown to ameliorate the dysregulation of gene expression in HD models systems [28], [29], [43], we used RT-qPCR to measure the level of expression of a set of genes of interest in the striatum and cerebellum of WT, R6/2, Hdac7+/- and R6/2-Hdac7+/- mice aged 15 weeks. These included striatal genes that are consistently down-regulated in mouse models of HD and in HD patient brains and cerebellar genes that have consistently altered expression patterns in both R6/2 and the HdhQ150 knock-in mouse model of HD [13], [42], [44]. We found that Hdac7 reduction did not ameliorate the transgene-mediated transcriptional dysregulation in the striatum (Figure 4A) or the cerebellum (Figure 4B) of 14 week old mice. However, the expression of Igfbp5 was increased with HDAC7 reduction in the cerebellum of WT (P = 0.047) but not R6/2 mice (P = 0.690) (Figure 4B). Concomitantly, we found no difference in R6/2 transgene expression in the striatum (P = 0.620) (Figure 4C) and the cerebellum (P = 0.240) (Figure 4D) of R6/2 and R6/2-Hdac7+/- mice.
###end p 32
###begin title 33
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Comparable changes in striatal and cerebellar gene expression changes between R6/2 and R6/2-HDAC7 mice.
###end title 33
###begin p 34
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Benn1">[44]</xref>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 500 507 500 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Darpp32</italic>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drd2</italic>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Penk1</italic>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Psme1</italic>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Uchl1</italic>
###xml 716 722 716 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igfbp5</italic>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
Relative expression ratios to the geometric mean of three housekeeping genes [44] for transcripts in striatum (A) and cerebellum (B) of 15 week old WT (white), Hdac7+/- (grey), R6/2 (black) and R6/2-Hdac7 (striped) mice. Error bars correspond to S.E.M. (n>8). * P<0.05. Hdac7 genotype does not modulate R6/2 transgene expression level in striatum (C) or cerebellum (D) of 15 week old mice R6/2 (black) and R6/2-Hdac7+/- (striped). Error bars correspond to S.E.M. (n>8). Cnr1, cannabinoid receptor 1; Darpp32, Dopamine and cAMP regulated neuronal phosphoprotein; Drd2, dopamine D2 receptor; Penk1, proenkephalin; Psme1, proteasome activator subunit 1 (PA28 alpha) Reg alpha; Uchl1, ubiquitin C-terminal hydrolase L1; Igfbp5, insulin-like growth factor binding protein 5.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly1">[23]</xref>
###xml 376 378 376 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Codd1">[37]</xref>
###xml 895 900 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC7</italic>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Dokmanovic1">[34]</xref>
###xml 990 997 990 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1065 1070 1065 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 1112 1116 <span type="species:ncbi:10090">mice</span>
We have previously shown that chronic administration of the HDAC inhibitor SAHA to R6/2 mice significantly improves some motor and neuropathological phenotypes [23]. However, the therapeutic index of SAHA in mice is very narrow, and therapeutic doses show considerable toxicity resulting in weight loss in both WT and R6/2 mice. SAHA has been reported to inhibit the eleven Zn2+ dependent HDAC enzymes [37] and therefore dissection of the mechanism through which SAHA exerts its beneficial effects is complex. In order to identify the HDAC enzyme(s) that are therapeutic targets for HD and in an attempt to separate the beneficial effects of SAHA from its toxicity, we have embarked on a series of genetic crosses to mice that have been genetically engineered to knock-out specific HDAC enzymes. HDAC7 is of additional interest because SAHA has been shown to decrease the level of expression of HDAC7 in a number of cell lines [34]. In this report we showed that these results extend to an in vivo system and that, after chronic administration, SAHA down-regulates Hdac7 mRNA levels in the brains of WT and R6/2 mice.
###end p 36
###begin p 37
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Chang1">[35]</xref>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac1</italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac1</italic>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac1</italic>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Schuettengruber1">[38]</xref>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac1</italic>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Lagger1">[45]</xref>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 773 778 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 880 885 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 892 897 892 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 982 987 982 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1115 1119 <span type="species:ncbi:10090">mice</span>
As nullizygosity for Hdac7 is embryonic lethal [35], it is not possible to investigate the effects of knocking-out the Hdac7 gene on the R6/2 phenotype. However, reduced levels of Hdac7 might be more akin to the effects to the pharmacological inhibition of this enzyme. We therefore established whether an investigation of the effects of knocking-down Hdac7 levels using Hdac7+/- knock-out mice would be feasible. This was necessary as it has been shown that the effects of the genetic knock-down of Hdac1 cannot be studied because Hdac1 mRNA and protein levels autoregulate to that of WT mice in Hdac1+/- mice [38] and furthermore, nullizygosity for Hdac1 is embryonic lethal [45]. We thus confirmed that Hdac7 expression is reduced in both the striatum and cerebellum of Hdac7+/- mice and that the presence of the R6/2 transgene does not alter Hdac7 expression levels in either Hdac7+/+ or Hdac7+/- mice at the mRNA or protein levels. We went on to show that genetic reduction of Hdac7 levels did not impact on the body weight, body temperature, RotaRod performance, grip strength or exploratory activity of R6/2 mice. Similarly, decreased Hdac7 expression did not ameliorate the HD-related dysregulated expression levels of a number of specific genes of interest.
###end p 37
###begin p 38
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Broide1">[46]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Bertos1">[47]</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Xu1">[31]</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Bertos1">[47]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Jensen2">[60]</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Bertos1">[47]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Schuetz1">[61]</xref>
###xml 1034 1038 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Gallinari1">[16]</xref>
###xml 1040 1044 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Xu1">[31]</xref>
###xml 1046 1050 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Martin1">[39]</xref>
###xml 1052 1056 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Bertos1">[47]</xref>
###xml 1058 1062 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Kato1">[49]</xref>
###xml 1064 1068 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Zhang1">[57]</xref>
###xml 1201 1209 1193 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1326 1330 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Kao2">[62]</xref>
###xml 1388 1396 1380 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1540 1544 1532 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Dokmanovic1">[34]</xref>
###xml 1925 1929 1917 1921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 132 135 <span type="species:ncbi:10116">rat</span>
###xml 2034 2038 <span type="species:ncbi:10090">mice</span>
Very little is currently known about the function of HDAC7 in brain. Hdac7 has previously been shown to be expressed throughout the rat brain by in situ hybridization [46]. Crucially, we established that Hdac7 is present in neurons, but were surprised to find that it could not be detected by immunohistochemistry in at least a proportion of non-neuronal brain cells. HDAC7 together with HDACs 4, -5 and -9 comprise the class IIa HDACs, which share a high degree of homology at their C-terminal catalytic domain [47]. The class IIa HDACs shuttle between the nucleus and cytoplasm and precise regulation of their subcellular distribution plays a pivotal role in modulating their function, via post-translational modifications such as phosphorylation, and the formation of nucleocytoplasmic shuttling complexes [31], [47]-[60]. Of the class IIa HDACs, HDAC7 is the most divergent [47], [61]. HDAC7 has been shown to associate with transcription co-repressors and factors such as CtBP, MEF2, HP1alpha, SMRT, N-CoR, mSin3A, and HIF1alpha [16], [31], [39], [47], [49], [57]. These interactions are consistent with the role of HDAC7 in regulating gene expression either as a co-activator or a co-repressor. In vitro studies with recombinant HDAC7 protein have suggested that histones may be substrates of HDAC7 deacetylase activity [62]. However, it has been shown that modulating HDAC7 levels in vitro by siRNA knockdown or overexpression is associated with growth arrest without detectable changes in histone acetylation or p21 gene expression [34]. This would be consistent with HDACs having many protein substrates, in addition to histones, involved in the regulation of gene expression, cell proliferation, and cell death and thus HDACs can be considered to be "lysine deactelylases". Although the functions of HDAC7 in brain are unknown and remain to be elucidated, our genetic studies lead us to conclude that inhibition of Hdac7 is not a major mediator of the beneficial effects that we obtained upon administration of SAHA to R6/2 mice and HDAC7 should not be prioritized as a therapeutic target for HD.
###end p 38
###begin title 39
Materials and Methods
###end title 39
###begin title 40
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse maintenance and breeding
###end title 40
###begin p 41
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly2">[40]</xref>
###xml 681 685 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac</italic>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">Mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 730 735 <span type="species:ncbi:10090">mouse</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">Mice</span>
Hemizygous R6/2 mice were bred and reared in our colony by backcrossing R6/2 males to (CBA x C57BL/6) F1 females (B6CBAF1/OlaHsd, Harlan Olac). Mice nullizygous for the Hdac7 gene are embryonic lethal but heterozygotes are viable and fertile. On arrival at our facility, the Hdac7+/- mice were on a SvEv129/C57Bl6 mixed background and once at King's College London were backcrossed to (C57Bl/6xCBA) F1 females seven times before breeding with R6/2 males. All animals had unlimited access to water and breeding chow (Special Diet Services, Witham, UK), and housing conditions and environmental enrichment were as previously described [40]. In the case of mice arising from the R6/2xHdac7+/- cross, all cages contained at least one mouse from each genotype and mice were additionally given mash consisting of powdered chow mixed with water from 12 weeks of age. Mice were subject to a 12 h light:12 h dark cycle. All experimental procedures were performed in accordance with Home Office regulations.
###end p 41
###begin title 42
Genotyping and CAG repeat sizing
###end title 42
###begin p 43
###xml 201 233 189 221 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCAGGCTAGGGCTGTCAATCATGCT-3&#8242;</named-content>
###xml 275 306 259 290 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCATCAGCTTTTCCAGGGTCGCCAT-3&#8242;</named-content>
###xml 588 611 542 565 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAGTCCCTCAAGTCCTTCCAGCA</named-content>
###xml 633 652 587 606 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCCAAACTCACGGTCGGT</named-content>
###xml 757 758 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 761 762 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 773 774 723 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 528 533 <span type="species:ncbi:10090">mouse</span>
R6/2 mice were identified by PCR of tail-tip DNA. For R6/2, a 10 microl reaction contained 100 ng DNA, 1x Thermo-Start master mix (Thermo Scientific), 1 microl DMSO, 10 ng/microl forward primer 33727 [5'-CGCAGGCTAGGGCTGTCAATCATGCT-3'], and 10 ng/microl reverse primer 32252 [5'-TCATCAGCTTTTCCAGGGTCGCCAT-3']. Cycling conditions were: 15 min @ 94degreesC, 35x (30 s @ 94degreesC; 30 s @ 60degreesC, 60 s @72degreesC) 10 min @ 72degreesC. The amplified R6/2 transgene product was 272 bp. Amplification of the CAG repeat from R6/2 mouse DNA was performed with a FAM labelled forward primer (GAGTCCCTCAAGTCCTTCCAGCA) and reverse primer (GCCCAAACTCACGGTCGGT) in 10 microl reactions containing: 0.2 mM dNTPs; 10% DMSO; AM buffer (67 mM TrisHCL pH 8.8; 16.6 mM (NH4)S04; 2 mM MgCl2; 0.17 mg/ml BSA) and 0.5 U AmpliTaq DNA polymerase (Applied Biosystems). Cycling conditions were: 90 s @ 94degreesC, 24x (30 s @ 94degreesC; 30 s @ 65degreesC; 90 s @ 72degreesC) 10 min @ 72degreesC. All instruments and materials were obtained from Applied Biosystems unless indicated. The FAM-tagged PCR product (1 microl) together with MegaBACEtrade mark ET900 (Amersham Bioscience) internal size standard (0.04 microl) were denatured at 94degreesC, 5 min in 9 microl of HiDi-formamide and analysed using an ABI3730 sequencer. Data analysis was performed using plate manager application GeneMapper v5.2- 3730XL.
###end p 43
###begin p 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hdac7</italic>
###xml 208 209 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 295 322 259 286 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTTGCAGGGTCAGCAGCGCAGGCTCTG</named-content>
###xml 396 424 352 380 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCAGTGGACGAGCATTCTGGAGAAAGGC</named-content>
###xml 495 524 443 472 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCAGTTTGAGGGGACGACGACAGTATCG</named-content>
###xml 545 548 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 583 584 519 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
Hdac7+/- mice were genotyped by multiplex PCR as follows: a 25 microl reaction contained 2 microl tail-tip genomic DNA (100 ng/microl), 2.5 microl 2 mM dNTPs, 5 microl 5x Promega Buffer, 1.5 microl 25 mM MgCl2, 2.5 microl DMSO, 1 microl (of 10 microM stock) primer "geno-SA 3" sequence (5'-3'): GTTGCAGGGTCAGCAGCGCAGGCTCTG, 0.45 microl (of 10 microM stock) primer "geno-SA 5-2" Sequence (5'-3'): CCAGTGGACGAGCATTCTGGAGAAAGGC, 0.55 microl (of 10 microM stock) primer "lacZ 3-2" Sequence (5'-3'): GCCAGTTTGAGGGGACGACGACAGTATCG, 0.2 microl Promega Taq (5 U/microl), and 12. 5 microl ddH2O. Cycling conditions were as follows: 95degreesC, 5 min, 35x (95degreesC, 30 s; 60degreesC, 30 s; 72degreesC, 45 s) and 72degreesC, 5 min before holding at 4degreesC. Wild-type product size was 400 bp whereas Het mice were indicated by a band at 640 bp.
###end p 44
###begin title 45
Phenotype analysis
###end title 45
###begin p 46
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly2">[40]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly2">[40]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Hockly3">[41]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
Mice were weighed weekly to the nearest 0.1 g. Motor coordination was assessed using an Ugo Basile 7650 accelerating RotaRod (Linton Instrumentation, UK), modified as previously described [40]. At 4 weeks of age, mice were tested on four consecutive days, with three trials per day. At 8, 10, 12 and 14 weeks of age, mice were tested on three consecutive days with three trials per day. Forelimb grip strength was measured once a week at 4, 7, 9, 11 and 13 weeks using a San Diego Instruments Grip Strength Meter (San Diego, CA, USA) as described [40]. Exploratory, spontaneous motor activity was recorded and assessed every two weeks at 5, 7, 9, 11 and 13 weeks of age for 60 min during the day using AM1053 activity cages, as described previously [41]. Briefly, activity (total number of beam breaks in the lower level), mobility (at least two consecutive beam breaks in the lower level) and rearing (number of rearing beam breaks) were measured. The data were collected and analyzed as described previously.
###end p 46
###begin title 47
RNA extraction and real-time PCR expression analysis
###end title 47
###begin p 48
###xml 147 151 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Benn1">[44]</xref>
###xml 576 580 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005747-Benn1">[44]</xref>
###xml 640 648 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005747.s001">Table S1</xref>
RNA extraction and reverse transcription of 4 microg of total cerebellar RNA and 1 microg total striatal RNA was performed as previously described [44]. The RT reaction was diluted 10-fold in nuclease free water (Sigma) and 5 microl was used in a 25 microl reaction containing Precision MasterMix (PrimerDesign), 400 nM primers and 300 nM probe using the Opticon 2 real-time PCR machine (MJ Research). Estimation of mRNA copy number was determined in duplicate for each RNA sample by comparison to the geometric mean of two or three endogenous housekeeping genes as described [44]. Primer and probe sequences are available in Supplementary Table S1.
###end p 48
###begin title 49
Antibodies and western blotting
###end title 49
###begin p 50
###xml 384 385 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 870 876 <span type="species:ncbi:9986">Rabbit</span>
###xml 882 887 <span type="species:ncbi:9606">human</span>
###xml 1195 1201 <span type="species:ncbi:9986">rabbit</span>
###xml 1202 1207 <span type="species:ncbi:10090">mouse</span>
Mouse brains were rapidly frozen in liquid nitrogen and stored at -80degreesC. Cortices were homogenized in ice cold buffer containing 0.32 mM sucrose, 10 mM Tris-HCl, 50 mM KCl, 1 mM EDTA, 0.1% Triton X-100, protein inhibitor cocktail (Roche) with the final pH adjusted to 7.8, followed by sonication for 6x10 s on ice (amplitude 30) (Vibracell Sonicator) and centrifugation at 2500xg for 15 min at 4degreesC. Protein concentration was determined using the BCA assay kit (Perbio). 50 microg protein lysates was fractionated on 8% SDS-PAGE gels and transferred into the Protran nitrocellulose membrane (Schleicher and Schuell) by submerged transfer apparatus (Bio-Rad) in (25 mM Tris, 192 mM glycine, 20%, v/v, methanol). Membranes were blocked for 30 min. at RT in 5% non-fat dried milk in PBS-Tween-20, incubated with gentle agitation over night at 4degreesC with the Rabbit anti-human HDAC7 antibody raised against peptide 1-13aa (1:250, CHDI Foundation) or alpha-Tubulin (1:40000, Sigma) (in PBS-Tween-20 with 1% non-fat dried milk). For chemiluminescent detection, blots were washed three times in PBST (PBS, 0.1% Tween-20), probed with HRP-linked secondary antibodies (HRP conjugated anti-rabbit mouse or anti-antibody (1:3000, Dako) (in PBS-Tween20 with 1% non-fat dried milk) for 1 h at RT and washed three times in PBST. Protein was detected by chemiluminescense (Femto WB detection system (Pierce) according to the manufacturer's instructions. The signals were quantified using a GS-800 calibrated densitometer (Bio-Rad).
###end p 50
###begin title 51
Immunohistochemistry and confocal microscopy
###end title 51
###begin p 52
###xml 314 320 <span type="species:ncbi:9913">bovine</span>
###xml 649 655 <span type="species:ncbi:9986">rabbit</span>
###xml 697 702 <span type="species:ncbi:10090">mouse</span>
###xml 779 785 <span type="species:ncbi:9793">donkey</span>
###xml 791 797 <span type="species:ncbi:9986">rabbit</span>
###xml 821 825 <span type="species:ncbi:9925">goat</span>
###xml 831 836 <span type="species:ncbi:10090">mouse</span>
Whole brains were frozen in isopentane, stored at 80degreesC and 15 microm thick sections were cut using a cryostat (Bright Instruments Ltd.). Sections were fixed for 10 min in methanol at -20degreesC and washed twice in 0.1 M phosphate buffered saline pH 7.4 (PBS) for 15 min before blocking in PBS containing 2% bovine serum albumin (BSA) and 0.1% Triton-X for 15 min. Sections were incubation in primary antibodies in PBS with BSA overnight at 4degreesC, washed twice in PBS for 15 min, incubated in secondary fluorescent antibodies in PBS with BSA for 1 hr at room temperature and washed twice in PBS for 15 min. Primary antibodies were: HDAC7 (rabbit polyclonal Sigma H2662) (1:50) and NeuN (mouse monoclonal Chemicon MAB377) (1:200) and secondary antibodies were: Alex-555 donkey anti-rabbit (1:1000) and Alexa 488 goat anti-mouse (1:1000) respectively (Molecular Probes). Nuclei were visualized using TO-PRO-3 (Molecular Probes) (1:1000). Slides were mounted in Mowial and antibody location was visualized using an LSM150 Meta confocal microscope (Zeiss).
###end p 52
###begin title 53
Statistical analysis
###end title 53
###begin p 54
Statistic analysis was performed by Student's t-test (Excel or SPSS), one-way ANOVA, two-way ANOVA and repeated measures GLM ANOVA, with the Greenhouse-Geisser correction for non-sphericity using SPSS.
###end p 54
###begin title 55
Supporting Information
###end title 55
###begin p 56
###xml 299 304 <span type="species:ncbi:9606">Human</span>
###xml 347 352 <span type="species:ncbi:9606">human</span>
Sequences of primers and Taqman probes used in real-time PCR assays. KEY: Cnr1 (Cannabinoid receptor 1); Darpp32 (Dopamine and cAMP regulated neuronal phosphoprotein, also known as Ppp1r1b, protein phosphatase 1, regulatory subunit 1B); Drd2 (Dopamine D2 receptor); Hdac (histone deacetylase); Htt (Human Huntington's disease gene, used to detect human exon 1 transgene); Igfbp5 (insulin-like growth factor binding protein 5 precursor); Pcp4 (Purkinje cell protein 4); Penk1 (Preproenkephalin); Uchl1 (ubiquitin carboxyl-terminal hydrolase L1).
###end p 56
###begin p 57
(0.03 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 144 148 <span type="species:ncbi:10090">mice</span>
We would like to thank Eric N. Olson at the University of Southwestern Medical Center at Dallas, Texas, USA for generously sharing the HDAC7+/- mice. In addition, we thank the CHDI Foundation for the HDAC7 antibody used for western blots.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
###end article-title 61
###begin article-title 62
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
###end article-title 62
###begin article-title 63
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.
###end article-title 63
###begin article-title 64
###xml 113 128 <span type="species:ncbi:10090">transgenic mice</span>
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
###end article-title 64
###begin article-title 65
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
###end article-title 65
###begin article-title 66
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.
###end article-title 66
###begin article-title 67
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation.
###end article-title 67
###begin article-title 68
###xml 93 108 <span type="species:ncbi:10090">transgenic mice</span>
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.
###end article-title 68
###begin article-title 69
Transcriptional signatures in Huntington's disease.
###end article-title 69
###begin article-title 70
Gene expression in Huntington's disease skeletal muscle: a potential biomarker.
###end article-title 70
###begin article-title 71
###xml 49 54 <span type="species:ncbi:9606">human</span>
Regional and cellular gene expression changes in human Huntington's disease brain.
###end article-title 71
###begin article-title 72
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
###end article-title 72
###begin article-title 73
Roles of histone acetyltransferases and deacetylases in gene regulation.
###end article-title 73
###begin article-title 74
Transcriptional regulation and the role of diverse coactivators in animal cells.
###end article-title 74
###begin article-title 75
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
###end article-title 75
###begin article-title 76
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.
###end article-title 76
###begin article-title 77
Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.
###end article-title 77
###begin article-title 78
###xml 30 52 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
###end article-title 78
###begin article-title 79
Histone deacetylase inhibitors reduce polyglutamine toxicity.
###end article-title 79
###begin article-title 80
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
Altered transcription in yeast expressing expanded polyglutamine.
###end article-title 80
###begin article-title 81
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
###end article-title 81
###begin article-title 82
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.
###end article-title 82
###begin article-title 83
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.
###end article-title 83
###begin article-title 84
Histone deacetylase inhibitors as therapeutics for polyglutamine disorders.
###end article-title 84
###begin article-title 85
Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death).
###end article-title 85
###begin article-title 86
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.
###end article-title 86
###begin article-title 87
###xml 114 129 <span type="species:ncbi:10090">transgenic mice</span>
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
###end article-title 87
###begin article-title 88
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
###end article-title 88
###begin article-title 89
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 81 84 <span type="species:ncbi:9606">men</span>
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.
###end article-title 89
###begin article-title 90
Histone deacetylase inhibitors: molecular mechanisms of action.
###end article-title 90
###begin article-title 91
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.
###end article-title 91
###begin article-title 92
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.
###end article-title 92
###begin article-title 93
Histone deacetylase inhibitors selectively suppress expression of HDAC7.
###end article-title 93
###begin article-title 94
Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.
###end article-title 94
###begin article-title 95
Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers.
###end article-title 95
###begin article-title 96
Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A.
###end article-title 96
###begin article-title 97
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Autoregulation of mouse histone deacetylase 1 expression.
###end article-title 97
###begin article-title 98
Class IIa histone deacetylases: regulating the regulators.
###end article-title 98
###begin article-title 99
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Standardization and statistical approaches to therapeutic trials in the R6/2 mouse.
###end article-title 99
###begin article-title 100
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
###end article-title 100
###begin article-title 101
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.
###end article-title 101
###begin article-title 102
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway.
###end article-title 102
###begin article-title 103
Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease.
###end article-title 103
###begin article-title 104
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression.
###end article-title 104
###begin article-title 105
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Distribution of histone deacetylases 1-11 in the rat brain.
###end article-title 105
###begin article-title 106
Class II histone deacetylases: structure, function, and regulation.
###end article-title 106
###begin article-title 107
Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7.
###end article-title 107
###begin article-title 108
Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity.
###end article-title 108
###begin article-title 109
Regulation of histone deacetylase activities.
###end article-title 109
###begin article-title 110
Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation.
###end article-title 110
###begin article-title 111
Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes.
###end article-title 111
###begin article-title 112
Signal-dependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodies.
###end article-title 112
###begin article-title 113
Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.
###end article-title 113
###begin article-title 114
CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3s.
###end article-title 114
###begin article-title 115
VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis.
###end article-title 115
###begin article-title 116
The structure and function of histone deacetylases: the target for anti-cancer therapy.
###end article-title 116
###begin article-title 117
Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis.
###end article-title 117
###begin article-title 118
Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
###end article-title 118
###begin article-title 119
Bone morphogenic protein 2 activates protein kinase d to regulate histone deacetylase 7 localization and repression of runx2.
###end article-title 119
###begin article-title 120
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity.
###end article-title 120
###begin article-title 121
Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.
###end article-title 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Competing Interests: The R6/2 mice are licensed by King's College London for commercial use.
###end p 122
###begin p 123
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Wellcome Trust, CHDI Foundation, Medical Research Council and Huntington's Disease Society of America Coalition for the Cure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 123

